Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
    • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Oct 24, 2023Oct 26, 2023Frazier Life Sciences Viii, L.P.
10%
BuyArcutis Biotherapeutics, Inc.ARQT$2.5$200,000+0.90%
Feb 11, 2022Feb 15, 2022Frazier Life Sciences Viii, L.P.
10%
BuyAlpine Immune Sciences, Inc.ALPN$7.1$799,989+7.06%
Feb 04, 2020Feb 06, 2020Frazier Life Sciences Viii, L.P.
10%
BuyArcutis Biotherapeutics, Inc.ARQT$17$9M+4.53%
Jan 09, 2020Jan 13, 2020Frazier Life Sciences Viii, L.P.
10%
SellEntasis Therapeutics Holdings Inc.ETTX$5$250,010-3.70%
Jan 18, 2019Jan 22, 2019Frazier Life Sciences Viii, L.P.
10%
BuyAlpine Immune Sciences, Inc.ALPN$5.37$2M+12.65%
Sep 28, 2018Oct 03, 2018Frazier Life Sciences Viii, L.P.
10%
BuyEntasis Therapeutics Holdings Inc.ETTX$15$6M+21.78%
Jun 25, 2018Jun 26, 2018Frazier Life Sciences Viii, L.P.
10%
BuyAptinyx Inc.APTX$16$2M+4.49%